Clinical Trial Update: QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA [Phase 1, Phase 2]

View source ↗

Summary

The document provides a clinical trial update on QUILT-3.038, a Phase 1/2 active immunotherapy vaccine targeting carcinoembryonic antigen (CEA) expressed by tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Prostate Cancer

Drugs mentioned

• CEA vaccine (carcinoembryonic antigen vaccine)

Snippet

Sponsor: NantCell, Inc. | Conditions: Colorectal Cancer, Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-11-25